Pharma
AstraZeneca and Ionis heart drug Wainua fails pivotal cardiomyopathy trial 0Pharma's biotech buying spree hits $123 billion in the first half of 2026 0Eli Lilly cuts 340B discounts to hospitals that withhold claims data 0CMS proposes closing a loophole drugmakers use to delay Medicare price negotiation 0